Utility of urinalysis to predict culture-positive urinary tract infection - a descriptive study from a tertiary care centre.
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2026 - Ongoing
Project Lead
Dr. Mamatha V
Authors
Dr. Mamatha V
Project Status
ongoing
Project Type
Undergraduate Research Grant for the year 2025–26